Ruth Palmer Lab
Ruth Palmer Lab
News
People
Events
Publications
Contact
Funding
Haiying Wan
Latest
The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN
Brigatinib, an anaplastic lymphoma kinase inhibitor, abrogates activity and growth in ALK-positive neuroblastoma cells, Drosophila and mice
Cite
×